Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 EUR | 0.00% | -0.67% | -20.59% |
Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
Sales 2024 * | 11.5M 12.49M | Sales 2025 * | 15M 16.29M | Capitalization | 138M 150M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 12 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 9.23 x |
P/E ratio 2024 * |
-9.9
x | P/E ratio 2025 * |
-22.8
x | Employees | 98 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 16.94% |
Latest transcript on Heidelberg Pharma AG
1 week | -0.67% | ||
Current month | -1.33% | ||
1 month | -1.00% | ||
3 months | -1.00% | ||
6 months | +6.83% | ||
Current year | -20.59% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Pahl
CEO | Chief Executive Officer | - | 11-12-31 |
Walter Miller
DFI | Director of Finance/CFO | - | 23-04-30 |
András Strassz
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 05-04-28 | |
Georg F. Baur
BRD | Director/Board Member | 74 | 00-12-13 |
Birgit Kudlek
BRD | Director/Board Member | 57 | 12-05-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 2.97 | 0.00% | 630 |
24-05-17 | 2.97 | 0.00% | 630 |
24-05-16 | 2.97 | -0.34% | 3,650 |
24-05-15 | 2.98 | +0.34% | 3,650 |
24-05-14 | 2.97 | -0.67% | 958 |
Delayed Quote Xetra, May 20, 2024 at 11:36 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.59% | 150M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- HPHA Stock